test publication

Page 1

2018/19
Annual Review

Welcome

At The Christie, we are proud of our history at the forefront of cancer care for more than a century, but we are even more proud of our forward thinking nature and our desire to constantly innovate and develop our services for the benefits of patients. We continue to lead the way in cancer care, research and education and remain committed to helping all those affected by cancer, both now and in the future.

97.4%

We treat more than 44,000 patients a year of patients would recommend The Christie as a provider of care CQC outstanding rating secured for second time

Our strategy

This year, having successfully achieved what we set out to do in our 2020 Vision strategy two years early, our new five year strategy was introduced, outlining our ambition to grow services even more for the benefit of our patients.

We went through an extensive process of consultation and engagement over the course of 12 months, adapting our original plans to embrace our vision for a truly world-class cancer centre.

Our strategy at The Christie remains focused on four key themes: Leading cancer care, The Christie experience, Local and specialist care, and Best outcomes. And we work hard to ensure everything we do is focused on achieving our goals in these areas.

Outstanding. Again.

2018/19 saw The Christie once again rated Outstanding by the Care Quality Commission (CQC), making us the first specialist trust in the country to be given its highest accolade twice.

2000

The CQC described The Christie

…a ‘leader in cancer care’ and a pioneer in developing innovative solutions to cancer care.

reconstructive surgery operations

104,000 radiotherapy treatments

70,000

SACT (chemo) treatments

The CQC described The Christie has ‘a leader in cancer care’ and a pioneer in developing innovative solutions to cancer care. It also praised the positive culture, our compassionate and effective leadership, and our exceptionally kind and caring staff who ‘go the extra mile to meet the needs of patients and their families’.

Proton beam therapy

After many years in preparation, we were delighted to finally start treating patients in our new proton beam therapy facilities at the end of December. We have an expert team in place and are proud to be the first NHS organisation in the UK to provide this specialist cancer treatment.

Gail’s story

Read more about all our achievements and our patients’ stories on our website: www.christie.nhs.uk

“ ”

Thanks to The Christie, within a very short space of time I went from despair at not knowing my future, to hope that I had a way forward.

Kay’s story

Improving patients’ experiences

The new outpatients department is bigger, brighter and more relaxing. It’s a much nicer place to be in when you come for your appointment.

We were delighted in February to mark the completion of our brand new £7m outpatient facility, offering a more accessible, spacious and comfortable environment for the 95,000 appointments that take place there each year.

Fully funded by The Christie charity, it aims to offer patients a more seamless experience with more consultation rooms, improved access to testing facilities and a new appointment system with self-check-in screens, helping to reduce patient waiting times and increase capacity.

MR-linac

As the year came to a close, we were also about to start treating our first patient with our revolutionary new MR-guided linear accelerator (MR-linac) - the first machine of its kind to combine magnetic resonance (MR) scanning and tumour-busting radiotherapy in one hi-tech package.

In order to fully unlock the potential of radiotherapy by making it even more precise, we need to be at the forefront of technology. This machine allows us to target cancer more accurately than ever before enabling us to avoid healthy tissue while delivering an increased radiation treatment. The £5.3M machine was part-funded by donations to The Christie charity.

I believe the treatment will give me a better quality of life and minimal side-effects in comparison to other treatments.

David Hutson – first patient to be treated on the MR-linac

NHS 70

In July, we were proud to play a major role in celebrating the 70th birthday of the NHS. This gave us an opportunity to showcase some of our life-saving work nationally, and culminated with an open day, where hundreds of visitors were welcomed behind the scenes to view some of the facilities which help make us world leaders in cancer care.

The Christie itself has a significant history of pioneering cancer treatment, research and education and has been at the forefront of cancer care for more than 100 years. We can’t help but be proud of our history, but it is vital we use that history to inspire us to pursue innovation and progression in an aim to provide world class care.

615 scientific, technical and therapeutic staff work at The Christie

Surgical robot demonstration at the open day
282
282 doctors work at The Christie 698 nurses work at The Christie
698

I am so lucky to be able to have my treatment at Salford as it so much nearer to my home in Wigan and means I don’t have to travel into Manchester every day.

Care closer to home

We affirmed our commitment to providing specialist cancer care local to patients’ homes where possible, by continuing to expand our chemotherapy outreach services.

In July we opened a new chemotherapy and blood service in Winsford in Cheshire, which will save many patients a round trip of up to three hours to our main site in South Manchester.

We also announced a major new fundraising appeal to build a state of the art new cancer centre in the heart of East Cheshire. The new Christie Cancer Centre will be built in the grounds of Macclesfield District General Hospital, providing Christie cancer care closer to home for more than 1,500 new patients a year.

22,500 chemotherapy outreach treatments closer to home

Polly’s story
Polly Bamber

Pushing the boundaries of research

The Christie’s research strength and capability continues to grow, delivering world-leading and life-changing research for the benefit of patients.

Much of our work is centred on developing personalised medicine approaches that target specific therapies to an individual patient’s cancer. We’re also focused on everything from prevention and early detection, through to living with and beyond cancer.

This year, the number of clinical trials at The Christie increased by 11 percent. More than 1800 patients benefited from access to 214 different clinical studies, making us one of the most active clinical research organisations in the UK. But behind every single one of those statistics is a life we have changed.

Geoff’s story

My medical team call me Mr Miracle. Thanks to a clinical trial, I’ve gone from planning my funeral to a complete return to health, enjoying life with my grandchildren.

11% increase in clinical trials in the last year 214 clinical studies took place 214 1800 patients on clinical trials 1800 11%

School of Oncology

Our School of Oncology continues to lead the way in the delivery of local, national and international programmes of education and training.

As the only one of its kind in the UK, the School of Oncology provides a teaching environment across all professions including medicine, nursing, clinical sciences, and the allied health professions, helping shape the expertise needed to treat cancer patients. 500

delegates attended the SoO organised Greater Manchester Cancer Conference
delegates attended our Enhanced Supportive Care Conference
staff trained nationally in diagnostic imaging via the PET-CT Academy 500 130
130
500

The Christie: a worldwide influence

Globally, The Christie is recognised as a leader in providing high quality patient-centred cancer care and has become increasingly influential internationally.

During the year we retained our international designation as a Comprehensive Cancer Centre of Excellence and also joined the Union for International Cancer Control (UICC) in its ambition to reduce the global cancer burden. Our experts are in demand to provide advice to cancer developments across the world.

A strategic research partnership between The Christie and Roche will aggregate clinical and genomic data and use advanced analytics to develop a world leading centre for the generation of real world evidence with the aim of speeding up research efforts to improve treatment and outcomes for cancer patients.

The Christie worked with Cork University Hospital (Eire) to help create a new radiotherapy centre.

The Christie welcomed delegations from around the world including Russia, Canada and Portugal.

The Christie has been chosen to provide advice on the cancer care element of a new hospitals development in China.

Experts from The Christie were invited to lecture in New Zealand.

Thanks to The Christie I’ve beaten cancer twice and fulfilled a lifelong dream to play at Wembley. Now it’s time for me to give something back by supporting The Christie charity.

Our generous supporters

raised by our charity £13.9m

£13.9M

50,000 active charity supporters

81p

81p in the £ goes to patient care

The Christie charity provides enhanced services over and above what the NHS funds. With more than 50,000 active supporters, our charity is vital in our quest to improve cancer treatment and research for all our patients.

This year our amazing army of supporters has raised £13.9m, enabling us to make huge investments in improving our services, funding everything from wigs for patients who lose their hair, to ground-breaking research facilities in our new proton beam therapy centre.

Joe’s story

Membership: keeping people involved

Being a member is a way of showing your support for The Christie. Members can be patients, friends, relatives, staff and members of the public.

Through the model of membership, people can influence the way we deliver our services and future strategies. By the end of March 2019 The Christie’s total membership was 19,547 members (including staff and volunteers). Having a large group of supporters providing a wide opinion base helps us to maintain a high profile for the Trust and develop the services we provide.

Financial performance

Our ability to take care of our patients reflects the financial health of the organisation. Every penny that we spend is used to support the people we care for so it is really important that we manage our finances well.

19,365 members

182 volunteers

28 governors

13 board of directors

Income

Expenditure

Capital

Research

Donations,

Share

Proton

Education

Non

Bank

2018-19 was another strong year for the Trust financially, reflecting the hard work and dedication from all of our staff to ensure that services are delivered in the most efficient and effective way for patients.

%
organisations 238.3 69.3%
Sustainability Fund 26.6 7.7%
£m
NHS
Provider
& development grants 17.9 5.2%
legacies and grants 13.6 3.9% Income generation 8.8 2.6% Joint venture income 8.8 2.6%
West Medical Physics 7.9 2.3%
North
of profit from joint 5.9 1.7% ventures
Beam Therapy 8.2 2.4%
and training grants 6.0 1.8%
patient care services to 0.6 0.2% other bodies
interest 0.8 0.3%
£m % Services from NHS bodies 9.5 3.0% Services from non-NHS bodies 7.8 2.5% Pay 132.7 42.1% Drug costs 73.3 23.3% Clinical supplies and services 23.1 7.3% Premises & Establishment 15.5 5.0% Depreciation 14.2 4.6% Other 38.9 12.3%
£m % Buildings under construction 34.3 85.4% Equipment 5.8 14.6%

The future

Everything we do at The Christie is with the future in mind and we know there will always be more we can do to improve the care and treatment we provide, and to boost our research and education.

We have already announced our plans to raise £23m to build a new cancer centre at Macclesfield in East Cheshire. The new centre will provide local specialist access to Christie radiotherapy, chemotherapy and clinical trials and is due to open in summer 2021.

1,500 patients will be treated at our new centre in Macclesfield

£23m

£23M being raised to fund new centre

Meanwhile, we’ve continued to develop our plans for a new state-of-the-art research facility. Integrating researchers and clinicians into one building, our aim is to become one of the world’s top five centres for basic, translational and clinical cancer research by 2025.

Plans are also underway to provide a redeveloped CT suite, allowing us to improve our facilities and benefit from the ever changing technology available to help doctors diagnose and treat cancers.

Keep up-to-date with all our news from the latest Christie developments to charity events.

The Christie NHS Foundation Trust

Wilmslow Road

Manchester M20 4BX

United Kingdom

Phone 0161 446 3000

Fax 0161 446 3977

www.christie.nhs.uk

Join the conversation on Twitter

Follow us @TheChristieNHS

Follow our charity @TheChristie

Join us on Facebook

www.facebook.com/TheChristieNHS

www.facebook.com/TheChristiecharity

Follow our charity on Instagram

www.instagram.com/christiecharity

Turn static files into dynamic content formats.

Create a flipbook